Lesotho

Lesotho

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
6.87 (5.54 - 8.26) 2019 Modelled IHME
7.27 (5.94 - 8.73) 2018 Modelled IHME
7.52 (6.13 - 9.06) 2017 Modelled IHME
7.61 (6.21 - 9.19) 2016 Modelled IHME
7.69 (6.26 - 9.33) 2015 Modelled IHME
7.84 (6.37 - 9.49) 2014 Modelled IHME
8.06 (6.54 - 9.68) 2013 Modelled IHME
8.31 (6.75 - 9.93) 2012 Modelled IHME
8.58 (6.94 - 10.23) 2011 Modelled IHME
8.82 (7.10 - 10.57) 2010 Modelled IHME
9.06 (7.24 - 10.89) 2009 Modelled IHME
9.3 (7.40 - 11.27) 2008 Modelled IHME
9.55 (7.58 - 11.71) 2007 Modelled IHME
9.78 (7.73 - 12.08) 2006 Modelled IHME
9.98 (7.81 - 12.40) 2005 Modelled IHME
10.17 (8.02 - 12.51) 2004 Modelled IHME
10.36 (8.12 - 12.62) 2003 Modelled IHME
10.53 (8.21 - 12.80) 2002 Modelled IHME
10.69 (8.31 - 12.94) 2001 Modelled IHME
10.81 (8.47 - 13.10) 2000 Modelled IHME
10.92 (8.58 - 13.19) 1999 Modelled IHME
11.01 (8.74 - 13.29) 1998 Modelled IHME
11.09 (8.83 - 13.49) 1997 Modelled IHME
11.17 (8.88 - 13.63) 1996 Modelled IHME
11.25 (8.95 - 13.76) 1995 Modelled IHME
11.32 (9.03 - 13.73) 1994 Modelled IHME
11.4 (9.09 - 13.69) 1993 Modelled IHME
11.47 (9.13 - 13.67) 1992 Modelled IHME
11.55 (9.18 - 13.73) 1991 Modelled IHME
11.62 (9.25 - 13.79) 1990 Modelled IHME
4.46 (0.46 - 35.31) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.59 (0.43 - 0.77) 2019 Modelled IHME
0.6 (0.44 - 0.77) 2018 Modelled IHME
0.62 (0.46 - 0.81) 2017 Modelled IHME
0.84 (0.62 - 1.09) 2016 Modelled IHME
1.13 (0.83 - 1.46) 2015 Modelled IHME
1.27 (0.93 - 1.63) 2014 Modelled IHME
1.37 (1.02 - 1.75) 2013 Modelled IHME
1.46 (1.10 - 1.86) 2012 Modelled IHME
1.55 (1.17 - 1.98) 2011 Modelled IHME
1.67 (1.25 - 2.14) 2010 Modelled IHME
1.81 (1.34 - 2.31) 2009 Modelled IHME
1.96 (1.44 - 2.50) 2008 Modelled IHME
2.14 (1.55 - 2.73) 2007 Modelled IHME
2.36 (1.69 - 3.04) 2006 Modelled IHME
2.66 (1.86 - 3.46) 2005 Modelled IHME
3.49 (2.46 - 4.54) 2004 Modelled IHME
4.98 (3.54 - 6.43) 2003 Modelled IHME
6.67 (4.79 - 8.61) 2002 Modelled IHME
8.09 (5.82 - 10.50) 2001 Modelled IHME
8.77 (6.28 - 11.41) 2000 Modelled IHME
8.91 (6.50 - 11.51) 1999 Modelled IHME
9 (6.56 - 11.56) 1998 Modelled IHME
9.07 (6.67 - 11.67) 1997 Modelled IHME
9.13 (6.69 - 11.71) 1996 Modelled IHME
9.19 (6.75 - 11.79) 1995 Modelled IHME
9.27 (6.83 - 11.83) 1994 Modelled IHME
9.34 (6.91 - 11.94) 1993 Modelled IHME
9.41 (6.92 - 12.13) 1992 Modelled IHME
9.48 (7.01 - 12.29) 1991 Modelled IHME
9.55 (7.07 - 12.51) 1990 Modelled IHME
1.64 (0.16 - 17.27) 2015 Modelled WHO
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
40 (31 - 52) 2019 Modelled IHME
40 (31 - 51) 2018 Modelled IHME
40 (30 - 51) 2017 Modelled IHME
40 (30 - 51) 2016 Modelled IHME
40 (30 - 51) 2015 Modelled IHME
40 (30 - 51) 2014 Modelled IHME
41 (31 - 52) 2013 Modelled IHME
41 (31 - 52) 2012 Modelled IHME
42 (31 - 52) 2011 Modelled IHME
42 (31 - 53) 2010 Modelled IHME
42 (31 - 53) 2009 Modelled IHME
42 (31 - 52) 2008 Modelled IHME
41 (31 - 52) 2007 Modelled IHME
41 (31 - 52) 2006 Modelled IHME
41 (31 - 52) 2005 Modelled IHME
42 (31 - 52) 2004 Modelled IHME
42 (32 - 53) 2003 Modelled IHME
42 (32 - 53) 2002 Modelled IHME
42 (33 - 53) 2001 Modelled IHME
42 (33 - 52) 2000 Modelled IHME
42 (33 - 52) 1999 Modelled IHME
42 (33 - 52) 1998 Modelled IHME
42 (33 - 52) 1997 Modelled IHME
41 (32 - 51) 1996 Modelled IHME
40 (32 - 50) 1995 Modelled IHME
40 (31 - 50) 1994 Modelled IHME
39 (30 - 49) 1993 Modelled IHME
39 (30 - 49) 1992 Modelled IHME
38 (29 - 49) 1991 Modelled IHME
38 (29 - 49) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
93 2018 Survey/reported WHO/UNICEF
93 2017 Survey/reported WHO/UNICEF
93 2016 Survey/reported WHO/UNICEF
93 2015 Survey/reported WHO/UNICEF
93 2014 Survey/reported WHO/UNICEF
93 2013 Survey/reported WHO/UNICEF
95 2012 Survey/reported WHO/UNICEF
96 2011 Survey/reported WHO/UNICEF
93 2010 Survey/reported WHO/UNICEF
91 2009 Survey/reported WHO/UNICEF
88 2008 Survey/reported WHO/UNICEF
90 2007 Survey/reported WHO/UNICEF
91 2006 Survey/reported WHO/UNICEF
87 2005 Survey/reported WHO/UNICEF
60 2004 Survey/reported WHO/UNICEF
17 2003 Survey/reported WHO/UNICEF
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.93 (1.54 - 2.43) 2019 Modelled IHME
1.94 (1.56 - 2.45) 2018 Modelled IHME
1.93 (1.55 - 2.47) 2017 Modelled IHME
1.9 (1.53 - 2.39) 2016 Modelled IHME
1.87 (1.49 - 2.34) 2015 Modelled IHME
1.86 (1.49 - 2.32) 2014 Modelled IHME
1.85 (1.49 - 2.29) 2013 Modelled IHME
1.85 (1.49 - 2.29) 2012 Modelled IHME
1.84 (1.49 - 2.29) 2011 Modelled IHME
1.84 (1.48 - 2.29) 2010 Modelled IHME
1.83 (1.48 - 2.27) 2009 Modelled IHME
1.81 (1.46 - 2.24) 2008 Modelled IHME
1.79 (1.45 - 2.23) 2007 Modelled IHME
1.77 (1.43 - 2.21) 2006 Modelled IHME
1.76 (1.41 - 2.19) 2005 Modelled IHME
1.74 (1.41 - 2.17) 2004 Modelled IHME
1.73 (1.40 - 2.16) 2003 Modelled IHME
1.72 (1.39 - 2.14) 2002 Modelled IHME
1.71 (1.38 - 2.13) 2001 Modelled IHME
1.69 (1.37 - 2.12) 2000 Modelled IHME
1.68 (1.36 - 2.11) 1999 Modelled IHME
1.67 (1.35 - 2.09) 1998 Modelled IHME
1.66 (1.34 - 2.08) 1997 Modelled IHME
1.65 (1.33 - 2.08) 1996 Modelled IHME
1.65 (1.32 - 2.08) 1995 Modelled IHME
1.65 (1.32 - 2.07) 1994 Modelled IHME
1.65 (1.32 - 2.07) 1993 Modelled IHME
1.65 (1.33 - 2.07) 1992 Modelled IHME
1.65 (1.33 - 2.06) 1991 Modelled IHME
1.66 (1.32 - 2.06) 1990 Modelled IHME
Showing out of
Show more

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
23 (15 - 33) 2019 Modelled IHME
23 (15 - 33) 2018 Modelled IHME
23 (15 - 33) 2017 Modelled IHME
24 (16 - 34) 2016 Modelled IHME
24 (16 - 34) 2015 Modelled IHME
24 (16 - 34) 2014 Modelled IHME
24 (16 - 34) 2013 Modelled IHME
24 (16 - 34) 2012 Modelled IHME
23 (15 - 34) 2011 Modelled IHME
23 (16 - 34) 2010 Modelled IHME
24 (16 - 34) 2009 Modelled IHME
24 (16 - 34) 2008 Modelled IHME
24 (16 - 33) 2007 Modelled IHME
24 (16 - 33) 2006 Modelled IHME
24 (16 - 33) 2005 Modelled IHME
24 (16 - 33) 2004 Modelled IHME
24 (16 - 33) 2003 Modelled IHME
24 (16 - 32) 2002 Modelled IHME
24 (16 - 32) 2001 Modelled IHME
24 (17 - 32) 2000 Modelled IHME
24 (17 - 32) 1999 Modelled IHME
24 (17 - 32) 1998 Modelled IHME
25 (18 - 33) 1997 Modelled IHME
26 (19 - 34) 1996 Modelled IHME
27 (19 - 35) 1995 Modelled IHME
28 (20 - 36) 1994 Modelled IHME
29 (20 - 38) 1993 Modelled IHME
29 (20 - 38) 1992 Modelled IHME
30 (20 - 39) 1991 Modelled IHME
30 (20 - 40) 1990 Modelled IHME
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
6.87 (%)
2019
(5.54 - 8.26(%))
IHME
HCV (RNA/cAg+)
1.93 (%)
2019
(1.54 - 2.43(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
168
2019
(92 - 258)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
165
2019
(104 - 245)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.59 (%)
2019, latest modelled
(0.43 - 0.77(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines